Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
By Mariel Padilla, The 19th
Tuesday's announcement is a long-awaited move intended to make the devices more accessible to millions of Americans with hearing problems.
By Matthew Perrone, Associated Press
Attorneys general from more than 40 states are alleging the nation’s largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions.
By Steve LeBlanc, Martin Crutsinger, Associated Press
Most adults say they struggle with remembering to take their prescriptions. A nationwide study is testing a pill with an ingestible sensor that tracks medication adherence from inside the body.
By Cat Wise
Only 2 percent of adults nationwide said the country’s opioid problem improved over the last year.
By Laura Santhanam
By Damian Garde, STAT
Amgen's cholesterol drug lowered risk of cardiovascular trouble in a huge clinical trial — but the results may not be good enough for insurers to cover.
By Jonathan J. Cooper, Associated Press
Frustrated by the rising cost of prescription drugs, California health advocates hope sunlight and a dose of shame will discourage drugmakers from raising their prices too quickly.
By Megan Thompson
In legal battles over drug patents, a brand-drug company will sometimes make a payment to a generic manufacturer that opponents allege is meant to delay the generic to market.
Should doctors be paid by pharmaceutical companies to promote their drugs?…
FDA plan to limit painkiller abuse may impact patients who need them…
Support Provided By: